Safety analysis of rFVII a with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program
Levy, Gallia G., Asikanius, Elina, Kuebler, Peter, Benchikh El Fegoun, Soraya, Esbjerg, Sille, Seremetis, StephanieLanguage:
english
Journal:
Journal of Thrombosis and Haemostasis
DOI:
10.1111/jth.14491
Date:
May, 2019
File:
PDF, 586 KB
english, 2019